Pharmaceutical

Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn

Mankind Pharma has announced a definitive agreement for the acquisition of Bharat Serums and Vaccines (BSV) for Rs136.3bn ($1.6bn).

Jul 28, 2024 - 04:00
Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
Mankind Pharma has announced a definitive agreement for the acquisition of Bharat Serums and Vaccines (BSV) for Rs136.3bn ($1.6bn).
Read the original article

Tags:

Previous Article

Roche records 4% decline in H1 2024 net income

Next Article

AbbVie’s Q2 2024 net earnings drop to $1.37bn

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Boehringer Ingelheim plans sustainability work for the long term

Boehringer Ingelheim plans sustainability work for the ...

Jul 12, 2024

STAT+: Dana-Farber, in break with Brigham and Women’s, will build new cancer center with Beth Israel

STAT+: Dana-Farber, in break with Brigham and Women’s, ...

Sep 14, 2023

FDA approves Accord BioPharma’s HERCESSI for cancer treatment

FDA approves Accord BioPharma’s HERCESSI for cancer tre...

Sep 20, 2024